Manifaxine


Manifaxine is a pharmaceutical drug that belongs to the class of antidepressants. It is primarily used in the treatment of major depressive disorder (MDD) and other related conditions. Manifaxine is known for its unique mechanism of action, which involves the modulation of various neurotransmitters in the brain.
Mechanism of Action[edit]
Manifaxine functions by inhibiting the reuptake of serotonin, norepinephrine, and dopamine, which are key neurotransmitters involved in mood regulation. By preventing the reabsorption of these neurotransmitters, Manifaxine increases their availability in the synaptic cleft, thereby enhancing neurotransmission and improving mood.
Indications[edit]
Manifaxine is indicated for the treatment of:
Dosage and Administration[edit]
Manifaxine is typically administered orally, with the dosage varying based on the severity of the condition and the patient's response to the treatment. It is important to follow the prescribed dosage and not to discontinue the medication abruptly to avoid withdrawal symptoms.
Side Effects[edit]
Common side effects of Manifaxine include:
Serious side effects may include:
Contraindications[edit]
Manifaxine is contraindicated in patients with:
- Known hypersensitivity to Manifaxine or any of its components
- Concurrent use of monoamine oxidase inhibitors (MAOIs)
- Severe liver impairment
Drug Interactions[edit]
Manifaxine may interact with other medications, including:
- Monoamine oxidase inhibitors (MAOIs)
- Selective serotonin reuptake inhibitors (SSRIs)
- Tricyclic antidepressants (TCAs)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
Pharmacokinetics[edit]
Manifaxine is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 2-4 hours after oral administration. It is metabolized primarily in the liver and excreted through the kidneys.
Research and Development[edit]
Ongoing research is being conducted to explore the potential of Manifaxine in treating other conditions such as bipolar disorder and post-traumatic stress disorder (PTSD).
See Also[edit]
References[edit]
External Links[edit]
-
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
